InvestorsHub Logo
Followers 3
Posts 1277
Boards Moderated 1
Alias Born 04/02/2003

Re: dreamz333 post# 17

Monday, 09/24/2007 2:17:40 PM

Monday, September 24, 2007 2:17:40 PM

Post# of 840
More info for you.

Have you ever seen an emerging company with a full scale sales force in place before their product was approved for marketing by the FDA??

But also please note=
"The Company's clinical trial results demonstrate healing rates of 68% (p-value of 0.125) and 81% (p-value of 0.036) for AutoloGel(tm) treated patients achieving total wound closure in the per-protocol (i.e. patients treated as provided in the study protocol) and majority-wound (i.e. wound sizes smaller than 7 sq cm in the per-protocol cohort) groups respectively. These are higher healing rates than those in any other similar data for other chronic wound treatment products with which the Company is familiar.

Cytomedix plans to leverage AutoloGel(tm)'s position as the only FDA cleared PRP gel system with a specific wound indication, the compelling results of the Company's clinical trial, as well as the unique competitive advantages of the distinct, patented formulation of AutoloGel(tm). The Company believes marketing clearance would enhance the Company's ability to secure Medicare and other third party coverage for AutoloGel(tm); develop further marketing data and achieve broad clinical acceptance; and, address the needs of large numbers of patients; all critical factors to the achievement of the Company's long-term strategic goals.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.